openPR Logo
Press release

Non-Small Cell Lung Cancer Market – Global Industry Insights, Trends, 2024

11-10-2017 12:44 PM CET | Health & Medicine

Press release from: Pharmaceutical

Non-Small Cell Lung Cancer Market – Global Industry Insights,

Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer Alliance (leading nonprofit organization dedicated to fighting lung cancer), out of overall lung cancer, around 80 to 85% cases found are of non-small cell lung cancer type and 15-20% cases found are of small cell lung cancer type.

The different, commonly diagnosed types of non-small cell lung cancer (NSCLC) are adenocarcinoma, squamous cell carcinoma, large cell carcinoma, large cell neuroendocrine tumors. Out of all these types adenocarcinoma and squamous cell carcinoma accounts around 60% of lung cancer.

There are no exact reason defined till yet by doctors behind lung cancer but some possible reasons are smoking, air pollution, mineral and metal dust, radiation treatment of chest or breast. The lung cancer symptoms are not noticeable in its early stage because they are considered for other type of illness for example pneumonia or collapsed lung. Some symptoms of lung cancer are chest pain, harsh/raspy sound during breathing, wheezing, weight loss, continuous coughing, hoarseness or voice changes, shortness of breath, lung problems like bronchitis or pneumonia etc. might be the symptoms of lung cancer. Also, if it spreads in other parts of the body then it shows symptoms like bone pain, weakness in arm or leg, yellow skin, yellow eyes, headache and balance problems.

Some diagnosis test are performed by doctors to detect the lung cancer includes diagnostic imaging test like X-ray, MRI, Ultrasound, CT scan and PET scan, also by checking the mucous when the patient cough up for cancer cells which is called as sputum cytology or also by taking the cells of your lungs from abnormal growth area of your lung or from the fluid of lungs which is called as fine needle aspiration biopsy, bronchoscopy and Mediastinoscopy.

Request For Sample Copy@
https://www.coherentmarketinsights.com/insight/request-sample/241

Non-small cell lung cancer market (NSCLC) taxonomy:

Global NSCLC Market by Type of NSCLC

Adenocarcinoma
Squamous cell carcinoma
Large cell carcinoma
Large cell neuroendocrine tumors
Global NSCLC Market by Type of Treatment

Surgery
Chemotherapy
Targeted therapy
Radiation therapy
Global NSCLC Market by Geography

North America
Europe
APAC
Latin America
Middle East
Africa
Increasing research and development on drugs and the prevalence of lung cancer are the major factors driving the growth of non-small cell lung cancer market

Non-small cell lung cancer is the leading cause of cancer related mortality in U.S. According to the data of American Cancer Society, Inc. (ACSI), NSCLC is the second most common type of cancer found in both men and women. As per the estimation of ACSI, in the year 2017 there will be around 222,500 new cases of lung cancer and 155,870 deaths will happen due to lung cancer in the united states.

Therefore, U.S. holds the largest market share of non-small cell lung cancer market followed by Europe as the large number of smokers are present in this region but in last few years the APAC region showed increased number of smokers. According to the stats of International Association for the Study of Lung Cancer (IASLC), China is the world’s largest consumer of tobacco having around 301 million smokers. While in western region the growth in number of smokers. According to the data published by World Health Organization (WHO), for the year 2012 there were around 58% of cases occurred in less developed regions.

The increasing prevalence and incident rate of lung cancer and emerging drugs will drive the market towards positive direction, also the increasing awareness about the treatment will support the growth of non-small cell lung cancer market. There are some growth restraining factors are also available that are less awareness about treatment options in emerging countries, availability of generic drugs, lack of research and development about drugs and increased expenditure on advertisements of tobacco products. According to the stats of IASLC, in 2012 tobacco industry spent $ 9.6 billion on tobacco products advertising and promotion which is 40 times greater than NIH research which spent $ 233 million on lung cancer research.

Some are the leading companies in non-small cell lung cancer are AstraZeneca Plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Agennix AG, ArQule Inc, GlaxoSmithKline Pharmaceuticals Limited, Daiichi Sankyo Co. Ltd., Sanofi-Aventis, and Boehringer Ingelheim GmbH. Also as per U.S. Food and Drug Administration some latest drug approvals in Market of non-small cell lung cancer by USFDA are on October 24, 2016 pembrolizumab (Merck & Co., Inc.) received approval, also FDA approved atezolizumab for the treatment of NSCLC on October 18, 2016.

Get More Details On this Report:
https://www.coherentmarketinsights.com/ongoing-insight/non-small-cell-lung-cancer-market-241

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentnews.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-Small Cell Lung Cancer Market – Global Industry Insights, Trends, 2024 here

News-ID: 811284 • Views:

More Releases from Pharmaceutical

Pharmaceutical Market Report 2018 Companies included CCM Pharmaceuticals, Pharmaniaga, Rosemont Pharmaceuticals, Simpor Pharma, Bosch Pharmaceuticals, NOOR VITAMINS and Others
Pharmaceutical Market Report 2018 Companies included CCM Pharmaceuticals, Pharma …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Equine Healthcare Market Global Industry Insights, Trends, 2026
Equine Healthcare Market Global Industry Insights, Trends, 2026
Equine Healthcare refers to the activities and practices aimed for the maintenance of horses. Equine healthcare offers the veterinary services intended for treating horses to enhance their quality of life, develop quality animal food and increase lifespan. The total equine population is directly proportional to the quality of equine healthcare. Equine healthcare includes a number of activities including diagnosis, therapies and supplements for maintaining internal health of horses. The
Novel Drug Delivery System (NDDS) Market - Global Industry Insights
Novel Drug Delivery System (NDDS) Market - Global Industry Insights
Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical compound in the body, and approaches needed to achieve the desired therapeutic effect. The side effects and slow processing of conventional drug therapy are contributing to the emergence of novel drug delivery system’s concept. Novel ideas based on interdisciplinary approaches controlling the pharmacodynamics, immunogenicity, pharmacokinetics, bio-recognition, and efficiency of drugs were generated. This new system helps in
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period 2016-2024
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 a …
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Introduction of novel approved drugs, expected to be commercialized post-2020, intended for treatment of suicidal ideation would be a major breakthrough for the global anti-suicide drugs market. Until recently, suicidal ideation has

All 5 Releases


More Releases for NSCLC

Huateng Pharma Supplies Intermeidates of Pemetrexed Against NSCLC
Pemetrexed disodium is a drug successfully developed by Eli Lilly in the United States for the treatment of tumors, patent protection to January 2017. Pemetrexed disodium is a multi-targeted anti-folate agent with a core pyrrolopyrimidine moiety in its structure. It is a dual inhibitor of nucleotide synthase/dihydrofolate reductase, which inhibits cell replication by disrupting the normal process of folate-dependent metabolism in cells and simultaneously blocking three different enzyme targets critical
NSCLC Market Global Industry Analysis and Forecast Till 2027
Any type of epithelial lung cancer that isn't small cell lung cancer is referred to as NSCLC (SCLC). Squamous cell carcinoma, large cell carcinoma, and adenocarcinoma are the most common kinds of NSCLC, although there are several more types that are less common, and all types can occur in atypical histologic variants. Request Sample Copy of this Report: https://www.infinitybusinessinsights.com/request_sample.php?id=562904 Top Key Players Included in This Report: Merck KGa, Roche, Nlyte, Taxotere,
Targeted Drugs for NSCLC Market Size by 2025: QY Research
Global Targeted Drugs for NSCLC market report is first of its kind research report that covers the overview, summary, market dynamics, competitive analysis, and leading player’s various strategies to sustain in the global market. This report covers five top regions of the globe and countries within, which shows the status of regional development, consisting of market value, volume, size, and price data. Apart from this, the report also covers detail
"NSCLC - Market Outlook and Competitive Landscape Report 2015 – 2030 "
Report Snapshot: NSCLC is the most common form of lung cancer, accounting for approximately 85% of all types and subtypes of lung cancer. It grows and spreads more slowly than small cell lung cancer. Early stage disease is associated with uncommon specific symptoms; hence roughly ~50% to 73% of cases are not being diagnosed until the disease is at an advanced stage when the chances for cure or significant patient benefit
Global Non-Small Cell Lung Cancer (NSCLC) Market- Current and Future Players
"The Report Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalData has released its pharma report, Non-Small Cell Lung Cancer (NSCLC) - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing NSCLC Market. The report identifies and analyses
Global cancer immunotherapies Market 2016:Melanoma, Prostate cancer, NSCLC
Cancer Immunotherapies has brought an unprecedented change in the global cancer therapies market. Cancer immunotherapy can be defined as, the treatment that deploys the bodys immune system, by joining and boosting innate powers of the immune system to fight cancer. Over the past few years, cancer immunotherapies have generated new waves of optimism in the global oncology market, unveiling huge untapped potential for the innovators. After years of jostling over how